AD02P3

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameAD02P3
Drug Alias NameAD02P3AD-02-P-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEnterococcus faecium infectionsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of British Columbia
China Registration ClassN/A

Develop Information

Active CompaniesAndira Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsEnterococcus faecium infectionsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A